Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.82 USD | +5.22% | +3.92% | +84.44% |
Apr. 17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
Apr. 10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+84.44% | 704M | |
+2.12% | 42.75B | |
+47.58% | 41.61B | |
+11.32% | 41.34B | |
-12.36% | 26.59B | |
+8.11% | 25.49B | |
-23.77% | 18.12B | |
+29.58% | 12.24B | |
-1.99% | 11.76B | |
+8.04% | 11B |
- Stock Market
- Equities
- NUVB Stock
- News Nuvation Bio Inc.
- Nuvation Bio Doses First Patient in Phase 1/2 Study of Advanced Solid Tumor Treatment